Edition:
United States

Alchemia Ltd (ACL.AX)

ACL.AX on Australia Stock Exchange

0.01AUD
28 Mar 2019
Change (% chg)

-- (--)
Prev Close
$0.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
832,865
52-wk High
$0.02
52-wk Low
$0.01

About

Alchemia Limited is a biotechnology company. The Company is engaged in the sale of its around the world intellectual property rights to Fondaparinum sodium, a generic anti-coagulant drug to Dr Reddy's Laboratories; closure of clinical trial activities, and review of new opportunities. The Company's segments include Fondaparinux... (more)
No analyst recommendations are available for .

Overall

Beta: -1.19
Market Cap(Mil.): $3.57
Shares Outstanding(Mil.): 324.72
Dividend: --
Yield (%): --

Financials

  ACL.AX Industry Sector
P/E (TTM): -- 97.98 34.52
EPS (TTM): -0.00 -- --
ROI: -19.35 7.77 12.69
ROE: -19.35 8.27 17.17

Earnings vs. Estimates